Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.
- DOI
- 10.1016/j.ijcha.2021.100763
- Published
- 2021 Jun
- Container
- International journal of cardiology. Heart & vasculature
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijcha.2021.100763,
title = {Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.},
author = {Azar RR and Ragy HI and Kozan O and El Khuri M and Bazergani N and Marler S and Teutsch C and Ibrahim M and Lip GYH and Huisman MV},
year = {2021},
journal = {International journal of cardiology. Heart \& vasculature},
doi = {10.1016/j.ijcha.2021.100763},
url = {https://doi.org/10.1016/j.ijcha.2021.100763}
}RIS
TY - JOUR TI - Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program. AU - Azar RR AU - Ragy HI AU - Kozan O AU - El Khuri M AU - Bazergani N AU - Marler S AU - Teutsch C AU - Ibrahim M AU - Lip GYH AU - Huisman MV PY - 2021 JO - International journal of cardiology. Heart & vasculature DO - 10.1016/j.ijcha.2021.100763 UR - https://doi.org/10.1016/j.ijcha.2021.100763 ER -
APA
RR, A., HI, R., O, K., M, E. K., N, B., S, M., C, T., M, I., GYH, L., & MV, H. (2021). Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.. International journal of cardiology. Heart & vasculature. https://doi.org/10.1016/j.ijcha.2021.100763
Source records
- pubmed · retrieved 2026-09-26T22:38:10.017Z